Ross\Johnson & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$621 Buy
6
+4
+200% +$357 0.01% 119
2026
Q1
$144 Sell
2
-3
-60% -$231 ﹤0.01% 193
2025
Q4
$397 Buy
5
+3
+150% +$237 0.01% 175
2025
Q3
$151 Hold
2
﹤0.01% 186
2025
Q2
$138 Sell
2
-26
-93% -$1.71K ﹤0.01% 189
2025
Q1
$1.9K Buy
+28
New +$1.68K 0.03% 173

Other funds holding CVS

Ross\Johnson & Associates's CVS Position: Q2 2026 in Review

Ross\Johnson & Associates increased its CVS Health (CVS) stake by 200% in Q2 2026, buying an estimated $357 and bringing the position to 6 shares worth $621. The position accounts for 0.01% of the portfolio, ranked #119.

Ross\Johnson & Associates first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.9K in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ross\Johnson & Associates held 6 shares of CVS Health worth $621 as of Q2 2026.
  • Ross\Johnson & Associates bought 4 CVS Health shares in Q2 2026, an estimated $357.
  • CVS Health made up 0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #119 holding.
  • Ross\Johnson & Associates first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's CVS Health position peaked at $1.9K in Q1 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.